Phoenix, Arizona -- July 18 2023 -- InvestorsHub NewsWire -- The
Stock Day Podcast welcomed Panacea Life Sciences Holdings, Inc.
(OTCQB: PLSH) ("the Company"), a holding company
structured to develop and facilitate manufacturing, research,
product development and distribution in the high-growth, natural
human and animal health & wellness market segment. Chief
Scientific Officer, James Baumgartner, PhD, joined Stock Day host
Kevin Davis.
Davis began the interview by asking about the Company's
background and current projects. "Panacea Life Sciences is a health
and wellness company," said Dr. Baumgartner. "We started off as an
industrial hemp cannabinoid company and what we've been doing is
harnessing our manufacturing capabilities for soft gels, liquid
fills, and topical lotions to make products that are going to
benefit people's everyday health," he shared. "This ranges from
cannabinoid medications and dietary supplements, as well as unique
skin moisturizers."
"Could you tell me more about your company's expansion into the
mushroom market?" asked Davis. "Functional mushrooms are
extraordinarily fascinating," said Dr. Baumgartner. "The mushroom
market is divided into three segments: functional mushrooms,
schedule one mushrooms, which contain psilocybin, and the Amanita
Muscaria mushroom," he explained. "We've been looking at each one
of these spaces in terms of developing new products to help people
with specific conditions or needs."
"How do mushrooms serve as dietary supplements?" asked Davis.
"One of the active compounds in mushrooms is called beta-glucan,"
said Dr. Baumgartner, before elaborating on different types of
mushrooms and their applications, which can include improved
memory, immune function, gut health, and exercise performance and
endurance.
"Could you elaborate on the Amanita Muscaria mushroom?" asked
Davis. "This is the mushroom that is seen all over the place," said
Dr. Baumgartner, adding that it can be easily identified by its red
color and white dots. "This mushroom has intoxicating properties,"
he said, noting that the mushroom has been used historically for
visions and healing properties. "The active component that produces
a euphoric feeling and intoxication is called muscimol," said Dr.
Baumgartner. "At smaller doses, this is a great sleep inducer and
at larger doses it will create a euphoric high."
"We also think this compound may help to improve anxiety and
could be useful for those experiencing mild forms of PTSD and
depression," continued Dr. Baumgartner. "Those are things that we
are taking a look at in terms of developing things into meaningful
products."
"How is Panacea working to develop these new sources for dietary
supplements?" asked Davis. "We have a collaboration with Colorado
State University to develop analytical methods to measure the
active components of each one of these mushroom species," said Dr.
Baumgartner, adding that this process also allows the company to
identify high levels of heavy metals in the mushrooms. "By
developing these methods with CSU, we can enter dietary supplement
clinical trials."
"The second thing that we are doing is blending different
natural ingredients together to create a better product," shared
Dr. Baumgartner, adding that the Company is working with
performance and endurance enhancing compounds and blending them
with ingredients like ginseng to further improve athletic
performance.
To close the interview, Dr. Baumgartner encouraged listeners and
shareholders to keep up-to-date on the Company's current and
upcoming projects as they continue to expand their portfolio of
cannabinoid and mushroom-based products in the health and wellness
industry.
To hear the entire interview with Dr. James Baumgartner, follow
the link to the podcast here:
Investors Hangout is a proud sponsor of "Stock Day," and
Stock Day Media encourages listeners to visit the company's message
board at
About Panacea Life Sciences Holdings, Inc.
Panacea Life Sciences Holdings, Inc. (OTCQB: PLSH) is a holding company structured to
develop and facilitate manufacturing, research, product development
and distribution in the high-growth, natural human and animal
health & wellness market segment. Its subsidiary, Panacea Life
Sciences, Inc. (PLS) is a woman-founded and led company dedicated
to manufacturing, distribution, research and production of the
highest-quality nutraceutical, cannabinoid, mushroom, kratom and
other natural, plant-based ingredients and products. PLS operates
out of a 51,000 square foot, state-of-the-art, cGMP facility in
Golden Colorado. If you would like more information, please
visit www.panacealife.com.
Cautionary Note Regarding Forward-Looking
Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995, including statements. Forward-looking statements involve
risks and uncertainties that could cause actual results to differ
materially from those projected or anticipated. These risks and
uncertainties include, but are not limited to, risks arising from
supply chain disruptions or our ability to obtain raw materials as
well as similar problems with our vendors, our ability to fulfill
purchase orders on a timely manner, our ability to fully collect
money for our purchase orders, the risk of customers returning our
products, impact of the pandemic including new variants on our
workforce, as well as those risks and uncertainties described by us
in our annual report on Form 10-K for the fiscal year ended
December 31, 2022 under the heading "Risk Factors." Any
forward-looking statement made by us herein speaks only as of the
date on which it is made. Factors or events that could cause our
actual results to differ may emerge from time to time, and it is
not possible for us to predict all of them. We undertake no
obligation to publicly update any forward-looking statement,
whether as a result of new information, future developments, or
otherwise, except as may be required by law.
Contact:
Nick Cavarra
info@panacealife.com
800-985-0515
About The "Stock Day" Podcast
Founded in 2013, Stock Day is the fastest growing media outlet
for Nano-Cap and Micro-Cap companies. It educates investors while
simultaneously working with penny stock and OTC companies,
providing transparency and clarification of under-valued,
under-sold Micro-Cap stocks of the market. Stock Day provides
companies with customized solutions to their news distribution in
both national and international media outlets. The Stock Day
Podcast is the number one radio show of its kind in America.
SOURCE:
Stock Day Media
StockDayMedia.Com
(602) 821-1102
Panacea Life Sciences (PK) (USOTC:PLSH)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Panacea Life Sciences (PK) (USOTC:PLSH)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025
